Anzeige
Mehr »
Freitag, 05.09.2025 - Börsentäglich über 12.000 News
Set to Action: Q-Gold vor drastischer Neubewertung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40QK8 | ISIN: US05330T2050 | Ticker-Symbol:
NASDAQ
04.09.25 | 22:00
1,075 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
AUTONOMIX MEDICAL INC Chart 1 Jahr
5-Tage-Chart
AUTONOMIX MEDICAL INC 5-Tage-Chart

Aktuelle News zur AUTONOMIX MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoAutonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment2
MiAutonomix Medical, Inc. - S-1/A, General form for registration of securities1
MiAutonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study2
27.08.Autonomix Medical erweitert Aktienverkaufsprogramm um 1,4 Mio. US-Dollar1
26.08.Autonomix Medical, Inc. - 8-K, Current Report2
20.08.Autonomix Medical, Inc. - S-1, General form for registration of securities1
20.08.Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology100Global patent estate encompasses 80 issued patents and 40 pending patent applications Strengthens strategic position in a multi-billion-dollar market opportunity across cardiovascular, renal, and...
► Artikel lesen
AUTONOMIX MEDICAL Aktie jetzt für 0€ handeln
14.08.Autonomix brings nerve-sensing catheter closer to clinical studies1
14.08.Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies269Microchip-based platform enables real-time nerve mapping and targeted treatment from within the vascular system Continued progress toward submitting Investigational Device Exemption ("IDE"), and if...
► Artikel lesen
13.08.Autonomix Medical, Inc. - 10-Q, Quarterly Report1
28.07.Autonomix Medical, Inc. - 10-K/A, Annual Report3
22.07.Autonomix Medical, Inc. - 8-K, Current Report1
22.07.Autonomix Medical Announces exercise of warrants for $2.5M gross proceeds1
22.07.Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds2
21.07.Autonomix Medical: Aktie legt nach Erteilung von Patent für "Smart Torquer"-Technologie zu-
21.07.Autonomix Medical stock gains after securing smart torquer patent1
21.07.Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications211With over 80 issued patents and 40 pending patent applications, Autonomix is building a comprehensive IP portfolio in nerve-sensing and modulation, strengthening its strategic position in a multi-billion-dollar...
► Artikel lesen
07.07.Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment1
30.06.Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase ("PoC 2") of Proof-of-Concept Human Clinical Study167Expansion of study into additional indications doubles the potential addressable market beyond pancreatic cancer pain PoC 2 phase builds on early success and positive results demonstrated in PoC 1...
► Artikel lesen
27.06.Autonomix erhält US-Patent für nervensensitive Medizintechnologie5
Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1